Rational selection of immunodominant and preserved epitope Sm043300e from Schistosoma mansoni and design of a chimeric molecule for biotechnological purposes

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Molecular Immunology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.molimm.2017.11.019PMID 29175593
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Biotechnological Applications of Marine Enzymes From Algae, Bacteria, Fungi, and Sponges.

  2017cited by this paper
• Epitopes rationally selected through computational analyses induce T‐cell proliferation in mice and are recognized by serum from individuals infected with Schistosoma mansoni

  2017cited by this paper
• Immunoinformatics analysis and in silico designing of a novel multi-epitope peptide vaccine against Staphylococcus aureus.

  2017cited by this paper
• Reverse vaccinology 2.0: Human immunology instructs vaccine antigen design

  2016cited by this paper
• The Use of Reverse Vaccinology and Molecular Modeling Associated with Cell Proliferation Stimulation Approach to Select Promiscuous Epitopes from Schistosoma mansoni

  2016cited by this paper
• Analysis of the DosR regulon genes to select cytotoxic T lymphocyte epitope specific vaccine candidates using a reverse vaccinology approach

  2016cited by this paper
• Workshop report: Schistosomiasis vaccine clinical development and product characteristics.

  2016cited by this paper
• Peptide-Based Immunotherapeutics and Vaccines 2015

  2015cited by this paper
• Fusion protein comprised of the two schistosomal antigens, Sm14 and Sm29, provides significant protection against Schistosoma mansoni in murine infection model

  2015cited by this paper
• Proteins and peptides for the immunodiagnosis and therapy of Mycobacterium tuberculosis infections

  2015cited by this paper
• Advances in the Diagnosis of Human Schistosomiasis

  2015cited by this paper
• Comparative Study of the Accuracy of Different Techniques for the Laboratory Diagnosis of Schistosomiasis Mansoni in Areas of Low Endemicity in Barra Mansa City, Rio de Janeiro State, Brazil

  2015cited by this paper
• Eliminating Schistosomes through Vaccination: What are the Best Immune Weapons?

  2015cited by this paper
• Mass spectrometric methods to analyze the structural organization of macromolecular complexes.

  2015cited by this paper
• Peptide-based synthetic vaccines

  2015cited by this paper
• The promise of reverse vaccinology.

  2015cited by this paper
• An overview of bioinformatics tools for epitope prediction: Implications on vaccine development

  2015cited by this paper
• Structure–function analysis of apical membrane‐associated molecules of the tegument of schistosome parasites of humans: prospects for identification of novel targets for parasite control

  2015cited by this paper
• Development of the Brazilian Anti Schistosomiasis Vaccine Based on the Recombinant Fatty Acid Binding Protein Sm14 Plus GLA-SE Adjuvant

  2015cited by this paper
• A novel multi-epitope peptide vaccine against cancer: an in silico approach.

  2014cited by this paper
• Peptide Vaccine: Progress and Challenges

  2014cited by this paper
• Peptide-Based Immunotherapeutics and Vaccines

  2014cited by this paper
• Discovery of novel cross-protective Rickettsia prowazekii T-cell antigens using a combined reverse vaccinology and in vivo screening approach.

  2014cited by this paper
• Molecular characterization and identification of Th1 epitopes of a Schistosoma japonicum protein similar to prosaposin

  2013cited by this paper
• Handles for Fmoc solid-phase synthesis of protected peptides.

  2013cited by this paper
• Analysis Tool Web Services from the EMBL-EBI

  2013cited by this paper
• Enhanced Protective Efficacy of a Chimeric Form of the Schistosomiasis Vaccine Antigen Sm-TSP-2

  2012cited by this paper
• Recombinant vaccines and the development of new vaccine strategies

  2012cited by this paper
• Peptide binding to HLA-DP proteins at pH 5.0 and pH 7.0: a quantitative molecular docking study

  2012cited by this paper
• Construction and Evaluation of a Novel Recombinant T Cell Epitope-Based Vaccine against Coccidioidomycosis

  2012cited by this paper
• Unfolding the conformational behavior of peptide dendrimers: insights from molecular dynamics simulations.

  2011cited by this paper
• In silico prediction of binding of promiscuous peptides to multiple MHC class-II molecules identifies the Th1 cell epitopes from secreted and transmembrane proteins of Schistosoma japonicum in BALB/c mice.

  2011cited by this paper
• GeneDB—an annotation database for pathogens

  2011cited by this paper
• Neuronal signaling in schistosomes: current status and prospects for postgenomics

  2010cited by this paper
• Improved side-chain torsion potentials for the Amber ff99SB protein force field

  2010cited by this paper
• Elucidating the transcriptome of Fasciola hepatica - a key to fundamental and biotechnological discoveries for a neglected parasite.

  2010cited by this paper
• Histamine signalling in Schistosoma mansoni: immunolocalisation and characterisation of a new histamine-responsive receptor (SmGPR-2).

  2010cited by this paper
• A Vaccine Encoding Conserved Promiscuous HIV CD4 Epitopes Induces Broad T Cell Responses in Mice Transgenic to Multiple Common HLA Class II Molecules

  2010cited by this paper
• AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading

  2009cited by this paper
• Investigation of a dopamine receptor in Schistosoma mansoni: functional studies and immunolocalization.

  2009cited by this paper
• Synthetic peptides as an antigenic base in an ELISA for laboratory diagnosis of schistosomiasis mansoni.

  2008cited by this paper
• BMC Bioinformatics BioMed Central Methodology article VaxiJen: a server for prediction of protective antigens, tumour

  2007cited by this paper
• Malaria vaccines: are we getting closer?

  2007cited by this paper
• Comparative Protein Structure Modeling Using MODELLER

  2007cited by this paper
• Protein-folding dynamics: overview of molecular simulation techniques.

  2007cited by this paper
• The schistosome in the mammalian host: understanding the mechanisms of adaptation

  2007cited by this paper
• Comparative Protein Structure Modeling Using Modeller

  2006cited by this paper
• HPLC techniques for proteomics analysis--a short overview of latest developments.

  2006cited by this paper
• Prediction of continuous B‐cell epitopes in an antigen using recurrent neural network

  2006cited by this paper
• Application of synthetic peptides in development of a serologic method for laboratory diagnosis of schistosomiasis mansoni.

  2006cited by this paper
• Tetraspanins on the surface of Schistosoma mansoni are protective antigens against schistosomiasis

  2006cited by this paper
• Statistical potential for assessment and prediction of protein structures

  2006cited by this paper
• Very fast empirical prediction and rationalization of protein pKa values

  2005cited by this paper
• Thermostat Algorithms for Molecular Dynamics Simulations

  2005cited by this paper
• Emerging concepts in GPCR function--the influence of cell phenotype on GPCR pharmacology.

  2005cited by this paper
• Immunodiagnosis of parasitic diseases with synthetic peptides.

  2003cited by this paper
• The use of HPLC-MS in T-cell epitope identification.

  2003cited by this paper
• This information is current as Lymphocyte Epitopes Immunogens Based on Multiple Th A Rational Strategy to Design Multiepitope

  2002cited by this paper
• The Protein Data Bank

  2000cited by this paper
• Reverse vaccinology.

  2000cited by this paper
• Increasing the potency of MHC class II-presented epitopes by linkage to Ii-Key peptide.

  2000cited by this paper
• Peptide Folding: When Simulation Meets Experiment

  1999cited by this paper
• Vaccine potential of a recombinant glutathione S-transferase cloned from Schistosoma haematobium in primates experimentally infected with an homologous challenge.

  1999cited by this paper
• A Schistosoma mansoni fatty acid-binding protein, Sm14, is the potential basis of a dual-purpose anti-helminth vaccine.

  1996cited by this paper
• Vaccination of patas monkeys experimentally infected with Schistosoma haematobium using a recombinant glutathione S‐transferase cloned from S. mansoni

  1995cited by this paper
• Basic local alignment search tool.

  1990cited by this paper
• MOPAC: A semiempirical molecular orbital program

  1990cited by this paper
• Multiple sequence alignment with hierarchical clustering.

  1988cited by this paper
• Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase.

  1988cited by this paper
• Comparison of simple potential functions for simulating liquid water

  1983cited by this paper

• Evaluating the Immunoprotective and Diagnostic Potential of Schistosoma mansoni Epitopes from Sm050890 and Sm141290 Proteins Identified Through Reverse Vaccinology

  2025cites this paper
• A mini-review on ELISA-Based Diagnosis of Schistosomiasis.

  2023cites this paper
• A reverse vaccinology approach identifies putative vaccination targets in the zoonotic nematode Ascaris

  2022cites this paper
• An Overview of Current Uses and Future Opportunities for Computer-Assisted Design of Vaccines for Neglected Tropical Diseases

  2021cites this paper
• AABC_A_258759 25..47

  2021cites this paper
• The potential for vaccines against scour worms of small ruminants.

  2020cites this paper
• Development of a conserved chimeric vaccine based on helper T-cell and CTL epitopes for induction of strong immune response against Schistosoma mansoni using immunoinformatics approaches.

  2019cites this paper
• The potential for vaccines against gastrointestinal nematodes of small ruminants

  2019cites this paper